Zinc finger protein 139 expression in gastric cancer and its clinical significance

World J Gastroenterol. 2014 Dec 28;20(48):18346-53. doi: 10.3748/wjg.v20.i48.18346.

Abstract

Aim: To investigate the expression of zinc finger protein 139 (ZNF139) in gastric cancer (GC), and to analyze its clinical significance.

Methods: A total of 108 patients who were diagnosed with GC and underwent surgery between January 2005 and March 2007 were enrolled in this study. Gastric tumor specimens and paired tumor-adjacent tissues were collected and paraffin-embedded, and the clinicopathologic characteristics and prognosis were recorded. The expression of ZNF139, Bcl-2, Bax, and caspase-3 were determined by immunohistochemistry, and apoptosis was assessed by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. SPSS 13.0 software was used for data processing and analyses, and significance was determined at P < 0.05.

Results: The expression of ZNF139 was stronger in tumors than in tumor-adjacent tissues (66.67% vs 44.44%; P < 0.01). Overexpression of ZNF139 correlated with tumor differentiation, invasion depth, clinical stage, lymphatic metastasis, and blood vessel invasion (all Ps < 0.05). Patients with overexpression of ZNF139 had a poorer prognosis (P < 0.01), and overexpression of ZNF139 was an independent factor for the prognosis of GC patients by a Cox survival analysis (P = 0.02). A negative relationship between ZNF139 and the apoptosis index was observed (r = -0.686; P < 0.01). The expression of Bcl-2 in GC was stronger than in tumor-adjacent tissues (66.67% vs 41.67%), whereas the expression levels of Bax and caspase-3 were lower in primary tumors (54.63% and 47.22%, respectively) than in tumor-adjacent tissues (73.15% and 73.15%, respectively) (all Ps < 0.05). The expression of ZNF139 negatively correlated with caspase-3 (r = -0.370; P < 0.01). The expressions of Bcl-2 and Bax were also negatively correlated (r = -0.231; P = 0.02). The expressions of caspase-3 and Bax protein were positively correlated (r = 0.217; P = 0.024).

Conclusion: ZNF139 is related to clinicopathologic characteristics and prognosis of GC. Furthermore, it is overexpressed and involved in apoptosis in GC tissues by regulating caspase-3.

Keywords: Apoptosis; Clinicopathologic characteristics; Gastric cancer; Prognosis; Zinc finger protein 139.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Apoptosis
  • Biomarkers, Tumor / analysis*
  • Caspase 3 / analysis
  • Cell Differentiation
  • Female
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Kruppel-Like Transcription Factors / analysis*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Proto-Oncogene Proteins c-bcl-2 / analysis
  • Risk Factors
  • Stomach Neoplasms / chemistry*
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery
  • Time Factors
  • Treatment Outcome
  • Up-Regulation
  • Young Adult
  • bcl-2-Associated X Protein / analysis

Substances

  • BAX protein, human
  • BCL2 protein, human
  • Biomarkers, Tumor
  • Kruppel-Like Transcription Factors
  • Proto-Oncogene Proteins c-bcl-2
  • ZKSCAN1 protein, human
  • bcl-2-Associated X Protein
  • CASP3 protein, human
  • Caspase 3